| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Carlsson A, Shore PA, Bro... |
Release of serotonin from blood platelets by reserpine in vitro |
J. Pharmacol. Exper.... |
1957 |
| Stacey RS |
Uptake of 5-hydroxytryptamine by platelets |
Brit. J. Pharmacol. |
1961 |
| Michal F |
D-Receptor for serotonin on blood platelets |
Nature |
1969 |
| Michal F |
Platelet aggregation by very low intensity acoustical energy and its i... |
Brit. J. Pharmacol. |
1970 |
| Gillis CN |
Metabolism of Vasoactive Hormones by Lung. |
Anesthesiology |
1973 |
| Torre M, Bogetto F, Torte... |
Effect of LSD-25 and l-Methyl-d-Lysergic Acid Butanolamide on Rat Brai... |
Psychopharmacologia ... |
1974 |
| Fanchamps A |
The Role of Humoral Mediators in Migraine Headache |
J Canad Sci Neurol |
1975 |
| Drummond AH, Gordon JL |
Inhibition of 5-Hydroxy-(3H)-tryptamine Binding to Rat Blood Platelets... |
Brit.J.Pharmacol. |
1975 |
| Klock JC, Boerner U, Beck... |
Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose,... |
Clinical Toxicology |
1975 |
| Saito H, Kitagawa H |
Mechanisms of the reversal of blood pressure by ephedrine |
Jap.J.Pharmacol. |
1976 |
| Boullin DJ, Glenton PAM |
Characterization of Receptors Mediating 5-Hydroxytryptamine and Catech... |
Brit.J.Pharmacol. |
1978 |
| Graf M, Pletscher A |
Pharmacological characterization of the 5-hydroxytryptamine (5HT) rece... |
Experientia (Basel) |
1978 |
| Da Prada M, Pieri L, Kell... |
Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... |
Ann.N.Y.Acad.Sci. |
1978 |
| Graf M, Pletscher A |
Shape Change Of Blood Platelets - a Model For Cerebral 5-hydroxytrypta... |
Brit.J.Pharmacol. |
1979 |
| Laubscher A, Pletscher A |
Shape Change And Uptake Of 5-hydroxytryptamine In Human Blood Platelet... |
Life Sci. |
1979 |
| Laubscher A, Pletscher A,... |
Blood platelets as models for neurons: receptor- and nonreceptor-media... |
Experientia |
1980 |
| Laubscher A, Pletscher A |
Increase of cyclic GMP in blood platelets by biogenic amines - a recep... |
J.Pharm.Pharmacol. |
1980 |
| Laubscher A, Pletscher A,... |
Interaction of D-LSD with Blood Platelets of Rabbits: Shape Change and... |
J Pharm and Exp Ther... |
1981 |
| Leysen JE, Gommeren W |
Characterization and quantification of serotonin-S2 receptor sites on ... |
Archives Internation... |
1984 |
| Leysen JE, De Chaffoy De ... |
Serotonin-s2 Receptor Binding Sites And Functional Correlates |
Neuropharmacology |
1984 |
| Geaney DP, Schachter M, E... |
Characterisation of [3H]Lysergic Acid Diethylamide Binding to a 5-Hydr... |
Europ J Pharmacol |
1984 |
| Schachter M, Geaney DP, G... |
Increased platelet membrane [3H]-LSD binding in patients on chronic ne... |
Br. J. Clin. Pharmac... |
1985 |
| Schachter M, Godfrey PP, ... |
Serotonergic Agonists Stimulate Inositol Lipid Metabolism In Rabbit Pl... |
Life Sciences |
1985 |
| Mathews JD, Riley MD, Fej... |
Effects of the heavy usage of kava on physical health: summary of a pi... |
Med J Aust |
1988 |
| Cozzi NV, Sievert MK, Shu... |
Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... |
Soc. Neurosci. Abs |
1988 |
| Britt SG, Gonias SL, Sand... |
Agonist and antagonist activities of arylpiperazines at human platelet... |
J Pharmacol Exp Ther |
1988 |
| Nash JF, Arora RC, Schrei... |
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... |
Biochem Pharmacol |
1991 |
| Rudnick G, Wall SC |
The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamin... |
Proc Natl Acad Sci |
1992 |
| Rudnick G, Wall SC |
Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serot... |
Mol Pharmacol |
1993 |
| Schuldiner S, Steiner-Mor... |
Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... |
Mol Pharmacol |
1993 |
| Shih JC, Chen K, Gallaher... |
Structure and Function of Serotonin 5-HT2 Receptors |
NIDA Research Monogr... |
1994 |
| Skop BP, Finkelstein JA, ... |
The serotonin syndrome associated with paroxetine, an over-the-counter... |
Am J Emerg Med |
1994 |
| Williams A, Unwin R |
Prolonged elevation of serum creatine kinase (CK) without renal failur... |
Nephrol Dial Transpl... |
1997 |
| Gleitz J, Beile A, Wilken... |
Antithrombotic action of the kava pyrone (+)-kavain prepared from Pipe... |
Planta Med |
1997 |
| Van Cauter E, Plat L, Sch... |
Simultaneous stimulation of slow-wave sleep and growth hormone secreti... |
J Clin Invest |
1997 |
| Mathews JD, Riley MD, Fej... |
Effects of the heavy usage of kava on physical health: summary of a pi... |
Med J Aust |
1998 |
| Cozzi NV, Shulgin AT, Ruo... |
Methcathinone (MCAT) and 2-methylamino-1-(3,4-methylenedioxyphenyl)pro... |
Amer. Chem. Soc. Div... |
1998 |
| Schirren CA, Berghaus TM,... |
Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... |
Ann Intern Med |
1999 |
| Cozzi NV, Sievert MK, Shu... |
Inhibition of plasma membrane monoamine transporters by beta-ketoamphe... |
Eur J Pharmacol |
1999 |
| Cozzi NV, Foley KF |
Methcathinone is a substrate for the serotonin uptake transporter |
Pharmacol Toxicol |
2003 |
| Ding EL, Hutfless SM, Din... |
Chocolate and prevention of cardiovascular disease: a systematic revie... |
Nutr Metab (Lond) |
2006 |
| Rose DZ, Guerrero WR, Mok... |
Hemorrhagic stroke following use of the synthetic marijuana spice |
Neurology |
2015 |
